Bogdan Agavriloaei

Hello

2025 IgAN KDIGO guidelines: fresh out of press, already aging gracefully — NephJC This week, we will discuss the 2025 KDIGO IgAN guidelines. which the shift from supportive care to structured, evidence-based therapy

The 2025 @kdigo.org IgAN guideline quietly redraws the map: new drugs, new thresholds, and a sense that the era of “supportive care only” is finally over #Nephsky #Medsky

✍️Summary by @thekidneywhisperer.bsky.social and
@glomerican.bsky.social

www.nephjc.com/news/igan-kd...

Protein supplementation in CKD: The Visual Abstract — NephJC We like protein, or do we? Low protein, high protein, supplements…what’s a nephrologist to do?

Check at the VA for our discussion of protein diet strategies by @msocomd.bsky.social. Is restricting protein in CKD and pushing protein in ESRD #TWDFNR?

www.nephjc.com/news/2025/10...

Up next! Everybody is welcome!

New era for kidney transplant?

Very important because safety concerne
#nephJC

Check out our next NephJC

New era for kidney transplant ?
Check out our NephJC blog!

NephJC 2025 Fall Pledge Drive — NephJC Help keep NephJC a vital, original, and unbiased source of medical education.

It's that time of year again 🍂🍂🍂
The #NephJC Fall pledge drive.
Plese give if you are able to support our decades long mission of #FOAMed for all. #NephSky #MedSky
www.nephjc.com/news/2025/9/22/nephjc-fall-pledge-drive

I don't know much about these #nephJC

most of the time

first line with one medication or combination of two drugs in a low dose? #nephJC

30-40% - hope so. #nephJC

TSH here ? haha. In a few situation a did that. #nephJC

Interesting. did they have the same lines from special categories ? (ADPKD/HD patients)#nephJC

YES

agavriloaei bogdan from Romania here #nephJC

Check out the VA!

PREVENT, Detect, Treat: What’s New in the 2025 Hypertension Toolkit — NephJC This week, we will discuss the AHA/ACC 2025 hypertension guideline update. Wow, have eight years flown by?

Change is in the Autumn air 🌬️🍂
Join use only on #Bluesky on 9/16/25 at 9pm EST.
We're discussing the 2025 ACC/AHA Hypertension Guideline Update. 🫀🫘🧠 #NephSky #MedSky
www.nephjc.com/news/accaha2025-klno3

Check this out!

Huge number of patients remain in both groups
#nephJC

We saw adherence in hyperkalemia but also we could exclude some of the patients with hyperkalemia, a possible frailty population that need more atention ? #nephJC

huge number of countries, so important #nephJC

Like most of the trials, ESKD are the patients that are mainly excluded. hope for some light with ACHIEVE in ESKD, it is ?

this is a very important one....aldosterone high - we need to block it, but how ? #nephJC

so hyperaldo is the key ? could we say that? #nephJC

Join us on nephJC chat!

An important subject and a hard one!

Thank for all the feedback until this work was done!

Agavriloaei bogdan from romania